NeuroOne

Country:
USA
Founding year:
2014

NeuroOne Medical is a neurotechnology company developing implantable thin-film electrode technology for use in neurosurgical and neurological procedures. The company focuses on improving precision, safety, and versatility of neural interfaces used for recording, stimulation, and therapeutic interventions.

Its platform consists of flexible, minimally invasive electrodes designed to conform to neural tissue and support multiple clinical functions, including EEG monitoring, cortical stimulation, and radiofrequency ablation. The technology is engineered to integrate with existing surgical workflows while reducing tissue disruption compared with conventional rigid electrodes.

NeuroOne Medical’s devices are intended for use in hospital and surgical settings, particularly in epilepsy monitoring, functional mapping, and neurosurgical treatment. The company positions its technology as enabling infrastructure for advanced neurosurgical care rather than a standalone consumer or wellness product.

Neuromodulation
Monitoring
OEM

Neurofounders Insights

Modality:
sEEG
Form Factor:
Implant
Interface Depth:
Minimally invasive
Indication:
Epilepsy
Target user:
Clinicians
Regulatory stage:
FDA cleared (501k)

Public

NeuroOne sits at the intersection of implantable electrodes and therapeutic intervention, with thin-film systems supporting recording, stimulation, and ablation in epilepsy care. Its FDA-cleared footprint gives it a practical edge over earlier-stage implant component companies.

Related companies

Articles featuring

NeuroOne

Press releases

No press releases published yet.